Zobrazeno 1 - 2
of 2
pro vyhledávání: '"L. M. Morsink"'
Autor:
L. M. Morsink, J. van Doesum, G. Choi, C. L. E. Hazenberg, A. Biswana, F. Meppelink, L. B. Bungener, A. J. A. Lambeck, G. Huls
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 1, Pp 1-3 (2022)
Externí odkaz:
https://doaj.org/article/a194596df02245308c9774ef6b8c0022
Publikováno v:
Clinical Pharmacokinetics, 62(4), 559-571. Springer International Publishing AG
BACKGROUND AND OBJECTIVE: Ruxolitinib is a tyrosine kinase inhibitor targeting the Janus kinase (JAK) and signal transducer and activator of transcription (STAT) pathways. Ruxolitinib is used to treat myelofibrosis, polycythemia vera and steroid-refr